Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2694

1.

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis - a systematic review and meta-analysis.

Kaneko Y, Kawahito Y, Kojima M, Nakayama T, Hirata S, Kishimoto M, Endo H, Seto Y, Ito H, Nishida K, Matsushita I, Kojima T, Kamatani N, Tsutani K, Igarashi A, Hasegawa M, Miyasaka N, Yamanaka H.

Mod Rheumatol. 2020 Jan 21:1-20. doi: 10.1080/14397595.2020.1719607. [Epub ahead of print]

PMID:
31960737
2.

Interleukin-4 as an emerging therapeutic target for IgG4-related disease.

Akiyama M, Kaneko Y, Takeuchi T.

Ann Rheum Dis. 2020 Jan 20. pii: annrheumdis-2020-216961. doi: 10.1136/annrheumdis-2020-216961. [Epub ahead of print] No abstract available.

PMID:
31959595
3.

ONO-7475, a novel AXL inhibitor, suppresses the adaptive resistance to initial EGFR-TKI treatment in EGFR-mutated non-small lung cancer.

Okura N, Nishioka N, Yamada T, Taniguchi H, Tanimura K, Katayama Y, Yoshimura A, Watanabe S, Kikuchi T, Shiotsu S, Kitazaki T, Nishiyama A, Iwasaku M, Kaneko Y, Uchino J, Uehara H, Horinaka M, Sakai T, Tanaka K, Kozaki R, Yano S, Takayama K.

Clin Cancer Res. 2020 Jan 17. pii: clincanres.2321.2019. doi: 10.1158/1078-0432.CCR-19-2321. [Epub ahead of print]

PMID:
31953310
4.

Silica gel solid nanocomposite electrolytes with interfacial conductivity promotion exceeding the bulk Li-ion conductivity of the ionic liquid electrolyte filler.

Chen X, Put B, Sagara A, Gandrud K, Murata M, Steele JA, Yabe H, Hantschel T, Roeffaers M, Tomiyama M, Arase H, Kaneko Y, Shimada M, Mees M, Vereecken PM.

Sci Adv. 2020 Jan 10;6(2):eaav3400. doi: 10.1126/sciadv.aav3400. eCollection 2020 Jan.

5.

Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.

Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H.

Intern Med. 2020;59(2):193-198. doi: 10.2169/internalmedicine.3358-19. Epub 2020 Jan 15.

6.

Coupling Reaction between Aldehydes and Non-Activated Hydrocarbons via the Reductive Radical-Polar Crossover Pathway.

Yahata K, Sakurai S, Hori S, Yoshioka S, Kaneko Y, Hasegawa K, Akai S.

Org Lett. 2020 Jan 15. doi: 10.1021/acs.orglett.0c00096. [Epub ahead of print]

PMID:
31939300
7.

Adult ALCAPA: from histological picture to clinical features.

Kubota H, Endo H, Ishii H, Tsuchiya H, Inaba Y, Terakawa K, Takahashi Y, Noma M, Takemoto K, Taniai S, Sakata K, Soejima K, Shimoyamada H, Kamma H, Kawakami H, Kaneko Y, Hirono S, Izumi D, Ozaki K, Minamino T, Yoshino H, Sudo K.

J Cardiothorac Surg. 2020 Jan 13;15(1):14. doi: 10.1186/s13019-020-1048-y.

8.

Usefulness of Urinary Creatinine/Urea Nitrogen Ratio as Indicator of Body Protein Catabolism in Dogs Fed Low Protein Diets.

Yamamoto S, Ohta Y, Hasegawa E, Hashida S, Kaneko Y, Mizutani S, Ong BHE, Naganobu K, Torisu S.

Front Vet Sci. 2019 Dec 10;6:449. doi: 10.3389/fvets.2019.00449. eCollection 2019.

9.

Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer.

Katayama Y, Shimamoto T, Yamada T, Takeda T, Yamada T, Shiotsu S, Chihara Y, Hiranuma O, Iwasaku M, Kaneko Y, Uchino J, Takayama K.

J Clin Med. 2019 Dec 31;9(1). pii: E102. doi: 10.3390/jcm9010102.

10.

Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study.

Tanaka Y, Kameda H, Saito K, Kaneko Y, Tanaka E, Yasuda S, Tamura N, Fujio K, Fujii T, Kojima T, Anzai T, Hamada C, Fujino Y, Matsuda S, Kohsaka H.

Mod Rheumatol. 2020 Jan 20:1-11. doi: 10.1080/14397595.2019.1709681. [Epub ahead of print]

PMID:
31903822
11.

Cobalt-Catalyzed Intermolecular Markovnikov Hydroamination of Nonactivated Olefins: N2-Selective Alkylation of Benzotriazole.

Yahata K, Kaneko Y, Akai S.

Org Lett. 2020 Jan 17;22(2):598-603. doi: 10.1021/acs.orglett.9b04375. Epub 2020 Jan 3.

PMID:
31898910
12.

Atypical Slow-Slow Atrioventricular Nodal Reentrant Tachycardia with Use of a Superior Slow Pathway.

Kaneko Y, Nakajima T, Iizuka T, Tamura S, Hasegawa H, Kurabayashi M.

Int Heart J. 2019 Dec 26. doi: 10.1536/ihj.19-082. [Epub ahead of print]

14.

Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function.

Miyatake D, Shibata T, Toyoshima J, Kaneko Y, Oda K, Nishimura T, Katashima M, Sakaki M, Inoue K, Ito T, Uchida N, Furihata K, Urae A.

Clin Pharmacol Drug Dev. 2019 Dec 12. doi: 10.1002/cpdd.751. [Epub ahead of print]

PMID:
31833184
15.

Oral administration of N-acetyl cysteine prevents osteoarthritis development and progression in a rat model.

Kaneko Y, Tanigawa N, Sato Y, Kobayashi T, Nakamura S, Ito E, Soma T, Miyamoto K, Kobayashi S, Harato K, Matsumoto M, Nakamura M, Niki Y, Miyamoto T.

Sci Rep. 2019 Dec 10;9(1):18741. doi: 10.1038/s41598-019-55297-2.

16.

Changes in components of the neurovascular unit in the retina in a rat model of retinopathy of prematurity.

Nakano A, Kondo R, Kaneko Y, Arima S, Asano D, Morita A, Sakamoto K, Nagamitsu T, Nakahara T.

Cell Tissue Res. 2019 Dec 2. doi: 10.1007/s00441-019-03112-9. [Epub ahead of print]

PMID:
31788758
17.

Mating-type switching and mating-type gene array expression in the methylotrophic yeast Ogataea thermomethanolica TBRC656.

Wongwisansri S, Promdonkoy P, Likhitrattanapisal S, Harnpichanchai P, Fujiyama K, Kaneko Y, Eurwilaichitr L, Ingsriswang S, Tanapongpipat S.

Microbiol Res. 2020 Feb;232:126372. doi: 10.1016/j.micres.2019.126372. Epub 2019 Nov 9.

PMID:
31759230
18.

Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer's Disease.

Shimizu S, Takenoshita N, Inagawa Y, Tsugawa A, Hirose D, Kaneko Y, Ogawa Y, Serisawa S, Sakurai S, Hirao K, Kanetaka H, Kanbayashi T, Imanishi A, Sakurai H, Hanyu H.

J Alzheimers Dis. 2020;73(1):117-123. doi: 10.3233/JAD-190958.

PMID:
31744010
19.

Translating intracarotid artery transplantation of bone marrow-derived NCS-01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into stem cell therapy.

Kaneko Y, Lee JY, Tajiri N, Tuazon JP, Lippert T, Russo E, Yu SJ, Bonsack B, Corey S, Coats AB, Kingsbury C, Chase TN, Koga M, Borlongan CV.

Stem Cells Transl Med. 2019 Nov 18. doi: 10.1002/sctm.19-0229. [Epub ahead of print]

20.

Withdrawal of deep brain stimulation in patients with gilles de la tourette syndrome.

Kimura Y, Ikegaya N, Iijima K, Takayama Y, Kaneko Y, Omori M, Kaido T, Kano Y, Iwasaki M.

Mov Disord. 2019 Dec;34(12):1925-1926. doi: 10.1002/mds.27909. Epub 2019 Nov 18. No abstract available.

PMID:
31737941
21.

Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function.

Miyatake D, Shibata T, Shibata M, Kaneko Y, Oda K, Nishimura T, Katashima M, Sekino H, Furihata K, Urae A.

Clin Drug Investig. 2019 Nov 15. doi: 10.1007/s40261-019-00873-7. [Epub ahead of print]

PMID:
31729626
22.

Multimodal visual exploration disturbances in Parkinson's disease detected with an infrared eye-movement assessment system.

Nagai K, Kaneko Y, Suzuki M, Teramoto H, Morita A, Kamei S, Watanabe Y, Okada M, Uchiyama M.

Neurosci Res. 2019 Nov 9. pii: S0168-0102(19)30443-2. doi: 10.1016/j.neures.2019.11.003. [Epub ahead of print]

PMID:
31715198
23.

Polymeric Nanocarriers With Mucus-Diffusive and Mucus-Adhesive Properties to Control Pharmacokinetic Behavior of Orally Dosed Cyclosporine A.

Sato H, Kaneko Y, Yamada K, Ristroph KD, Lu HD, Seto Y, Chan HK, Prud'homme RK, Onoue S.

J Pharm Sci. 2020 Feb;109(2):1079-1085. doi: 10.1016/j.xphs.2019.10.043. Epub 2019 Nov 4.

PMID:
31697948
24.

Signet ring cell carcinoma and poorly differentiated adenocarcinoma in a gastric hyperplastic polyp with lymphatic invasion: A case report.

Takahashi K, Saito S, Kaneko Y, Matsumoto S, Yamaguchi H, Kitayama J, Hosoya Y, Kawata H, Lefor AK, Sata N.

Int J Surg Case Rep. 2019;64:180-183. doi: 10.1016/j.ijscr.2019.10.019. Epub 2019 Oct 17.

25.

Is intracranial electroencephalography useful for planning resective surgery in intractable epilepsy with ulegyria?

Takayama Y, Ikegaya N, Iijima K, Kimura Y, Muraoka N, Kaneko Y, Yamamoto T, Iwasaki M.

J Neurosurg. 2019 Oct 25:1-6. doi: 10.3171/2019.8.JNS191642. [Epub ahead of print]

PMID:
31653813
26.

Superacid-Catalyzed Preparation of Highly Dispersible Zirconium Oxide and Titanium Oxide Nanoparticles Without Hydrocarbon Units.

Nakahara T, Kaneko Y.

J Nanosci Nanotechnol. 2020 May 1;20(5):2755-2762. doi: 10.1166/jnn.2020.17438.

PMID:
31635612
27.

Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial.

Tanaka Y, Oba K, Koike T, Miyasaka N, Mimori T, Takeuchi T, Hirata S, Tanaka E, Yasuoka H, Kaneko Y, Murakami K, Koga T, Nakano K, Amano K, Ushio K, Atsumi T, Inoo M, Hatta K, Mizuki S, Nagaoka S, Tsunoda S, Dobashi H, Horie N, Sato N.

Ann Rheum Dis. 2020 Jan;79(1):94-102. doi: 10.1136/annrheumdis-2019-216169. Epub 2019 Oct 19.

28.

Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.

Takei Y, Takahashi S, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.

PLoS One. 2019 Oct 15;14(10):e0223703. doi: 10.1371/journal.pone.0223703. eCollection 2019.

29.

Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines.

Tachikawa M, Kaneko Y, Ohtsuki S, Uchida Y, Watanabe M, Ohtsuka H, Terasaki T.

J Pharm Sci. 2020 Feb;109(2):1161-1168. doi: 10.1016/j.xphs.2019.09.024. Epub 2019 Oct 9.

PMID:
31605689
30.

Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case-control study.

Namikawa H, Niki M, Niki M, Yamada K, Nakaie K, Sakiyama A, Oinuma KI, Tsubouchi T, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H.

Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2291-2297. doi: 10.1007/s10096-019-03676-y. Epub 2019 Oct 11.

PMID:
31605255
31.

Attenuation of renal fibrosis after unilateral ureteral obstruction in mice lacking the N-type calcium channel.

Mishima K, Nakasatomi M, Takahashi S, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.

PLoS One. 2019 Oct 9;14(10):e0223496. doi: 10.1371/journal.pone.0223496. eCollection 2019.

32.

Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer.

Yoshimura A, Yamada T, Miyagawa-Hayashino A, Sonobe Y, Imabayashi T, Yamada T, Okada S, Shimamoto T, Chihara Y, Iwasaku M, Kaneko Y, Uchino J, Inoue M, Konishi E, Takayama K.

Lung Cancer. 2019 Nov;137:108-112. doi: 10.1016/j.lungcan.2019.09.012. Epub 2019 Sep 16.

PMID:
31568887
33.

Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma.

Takeda M, Ohe Y, Horinouchi H, Hida T, Shimizu J, Seto T, Nosaki K, Kishimoto T, Miyashita I, Yamada M, Kaneko Y, Morimoto C, Nakagawa K.

Lung Cancer. 2019 Nov;137:64-70. doi: 10.1016/j.lungcan.2019.09.010. Epub 2019 Sep 16.

34.

Osimertinib in first line setting: for Asian patients.

Onoi K, Kaneko Y, Uchino J.

Transl Lung Cancer Res. 2019 Aug;8(4):550-552. doi: 10.21037/tlcr.2019.03.06. No abstract available.

35.

Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study).

Iwasaku M, Uchino J, Yamada T, Chihara Y, Shimamoto T, Tamiya N, Kaneko Y, Kiyomi F, Takayama K.

Transl Lung Cancer Res. 2019 Aug;8(4):519-523. doi: 10.21037/tlcr.2019.08.03.

36.

Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients.

Yoshimura A, Yamada T, Okuma Y, Kitadai R, Takeda T, Kanematsu T, Goto H, Yoneda H, Harada T, Kubota Y, Yamada T, Date K, Shiotsu S, Nagata K, Chihara Y, Kaneko Y, Uchino J, Nishioka Y, Takayama K.

Transl Lung Cancer Res. 2019 Aug;8(4):450-460. doi: 10.21037/tlcr.2019.08.07.

37.

Reduction of air leakage using linear staple device with bioabsorbable polyglycolic acid felt for pulmonary lobectomy.

Deguchi H, Tomoyasu M, Shigeeda W, Kaneko Y, Kanno H, Saito H.

Gen Thorac Cardiovasc Surg. 2019 Sep 20. doi: 10.1007/s11748-019-01207-2. [Epub ahead of print]

PMID:
31541348
38.

Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis.

Tsubouchi K, Araya J, Yoshida M, Sakamoto T, Koumura T, Minagawa S, Hara H, Hosaka Y, Ichikawa A, Saito N, Kadota T, Kurita Y, Kobayashi K, Ito S, Fujita Y, Utsumi H, Hashimoto M, Wakui H, Numata T, Kaneko Y, Mori S, Asano H, Matsudaira H, Ohtsuka T, Nakayama K, Nakanishi Y, Imai H, Kuwano K.

J Immunol. 2019 Oct 15;203(8):2076-2087. doi: 10.4049/jimmunol.1801232. Epub 2019 Sep 18.

PMID:
31534007
39.

IgG4-Related Disease: A Growing Appreciation of Follicular Helper T Cell Expansion.

Akiyama M, Suzuki K, Kaneko Y, Takeuchi T.

Clin Transl Gastroenterol. 2019 Sep;10(9):e00076. doi: 10.14309/ctg.0000000000000076. No abstract available.

40.

Combined subtotal gastrectomy and splenectomy after partial splenic embolization for a patient with gastric cancer and immune thrombocytopenic purpura: A case report.

Kaneko Y, Saito S, Takahashi D, Ui T, Haruta H, Kurashina K, Yamaguchi H, Hosoya Y, Kitayama J, Lefor AK, Sata N.

Int J Surg Case Rep. 2019;62:140-143. doi: 10.1016/j.ijscr.2019.08.027. Epub 2019 Aug 31.

41.

Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab.

Yamada H, Kaneko Y, Tamai H, Takeuchi T.

Rheumatology (Oxford). 2019 Sep 5. pii: kez392. doi: 10.1093/rheumatology/kez392. [Epub ahead of print] No abstract available.

PMID:
31504968
42.

Craving for Gambling Predicts Income-Generating Offenses: A Pathways Model of a Japanese Prison Population.

Yokotani K, Tamura K, Kaneko Y, Kamimura E.

J Gambl Stud. 2019 Aug 24. doi: 10.1007/s10899-019-09887-4. [Epub ahead of print]

PMID:
31446551
43.

Selective endovascular cooling for stroke entails brain-derived neurotrophic factor and splenic IL-10 modulation.

Corey S, Abraham DI, Kaneko Y, Lee JY, Borlongan CV.

Brain Res. 2019 Nov 1;1722:146380. doi: 10.1016/j.brainres.2019.146380. Epub 2019 Aug 12.

PMID:
31415765
44.

A V-A-V response during induction of supraventricular tachycardia: What is the mechanism?

Kaneko Y, Nakajima T, Tamura S, Hasegawa H, Kurabayashi M.

J Arrhythm. 2019 Jun 25;35(4):692-695. doi: 10.1002/joa3.12216. eCollection 2019 Aug. No abstract available.

45.

Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study.

Kaneko Y, Nunokawa T, Taniguchi Y, Yamaguchi Y, Gono T, Masui K, Kawakami A, Kawaguchi Y, Sato S, Kuwana M; JAMI investigators .

Rheumatology (Oxford). 2020 Jan 1;59(1):112-119. doi: 10.1093/rheumatology/kez238.

PMID:
31382295
46.
47.

Empathy in stroke rats is modulated by social settings.

Shinozuka K, Tajiri N, Ishikawa H, Tuazon JP, Lee JY, Sanberg PR, Zarriello S, Corey S, Kaneko Y, Borlongan CV.

J Cereb Blood Flow Metab. 2019 Aug 1:271678X19867908. doi: 10.1177/0271678X19867908. [Epub ahead of print]

PMID:
31366299
48.

Role of the voltage sensor module in Nav domain IV on fast inactivation in sodium channelopathies: The implication of closed-state inactivation.

Nakajima T, Kaneko Y, Dharmawan T, Kurabayashi M.

Channels (Austin). 2019 Dec;13(1):331-343. doi: 10.1080/19336950.2019.1649521.

49.

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).

Tanaka Y, Takeuchi T, Tanaka S, Kawakami A, Iwasaki M, Song YW, Chen YH, Wei JC, Lee SH, Rokuda M, Izutsu H, Ushijima S, Kaneko Y, Akazawa R, Shiomi T, Yamada E.

Ann Rheum Dis. 2019 Oct;78(10):1320-1332. doi: 10.1136/annrheumdis-2019-215163. Epub 2019 Jul 26.

50.

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.

Takeuchi T, Tanaka Y, Tanaka S, Kawakami A, Iwasaki M, Katayama K, Rokuda M, Izutsu H, Ushijima S, Kaneko Y, Shiomi T, Yamada E, van der Heijde D.

Ann Rheum Dis. 2019 Oct;78(10):1305-1319. doi: 10.1136/annrheumdis-2019-215164. Epub 2019 Jul 26.

Supplemental Content

Loading ...
Support Center